Scientists at the Mainz University Medical Center and the Max Planck Institute for Polymer Research (MPI-P) have developed a new method to enable miniature drug-filled nanocarriers to dock on to immune cells, which in turn attack tumors. In the future, this may lead to targeted treatment that can largely eliminate damage to healthy tissue. The scientists have recently published their findings in the renowned scientific journal Nature Nanotechnology.
Professor Volker Mailänder and his team from the Department of Dermatology at the University Medical Center of Johannes Gutenberg University Mainz (JGU) have recently developed an ingenious new method of binding antibodies to such drug capsules. “Up to now, we have always had to use elaborate chemical methods to bind these antibodies to nanocapsules,” explained Mailänder. “We have now been able to show that all that you need to do is to combine antibodies and nanocapsules together in an acidified solution.”
Image Credit: Stefan Schuhmacher
News This Week
What to know about BA.2 – the newest Covid Omicron variant
It's called the "stealth" variant, but there's nothing particularly stealthy about it. Researchers are working to parse whether it is a new threat. As coronavirus case numbers in the U.S. show early signs of [...]
New, better coronavirus rapid test
Researchers at the Paul Scherrer Institute PSI and the University of Basel have developed a rapid test for COVID-19. Its novel functional principle promises reliable and quantifiable results concerning a patient's COVID-19 disease and [...]
Bio-Inspired Nanocoating Improves NIR and Biomedical Properties of Titanium Alloy
A group of researchers proposed an optimized electroforming strategy to achieve a bioinspired nano-holed TiO2 coated Ti6Al4V alloy, according to a study published in the journal ACS Applied Material Interfaces. Near-infrared (NIR) energy plays a critical part [...]
Seeking a hydrophilic nanoparticle solution to antibiotic resistance
The Centers for Disease Control and Prevention estimates that more than 2.8 million Americans experience antibiotic-resistant infections each year; more than 35,000 die from those infections. To address this critical and worldwide public health [...]
Nano-sized vesicles with ACE2 receptor could prevent, treat infection of SARS-CoV-2
Scientists at The University of Texas MD Anderson Cancer Center and Northwestern Medicine have identified natural extracellular vesicles containing the ACE2 protein (evACE2) in the blood of COVID-19 patients that can block infection from [...]
‘Superpower’ nano bubbles could treat, prevent current and future strains of SARS-CoV-2
Scientists at Northwestern Medicine and The University of Texas MD Anderson Cancer Center have identified natural nano-bubbles containing the ACE2 protein (evACE2) in the blood of COVID-19 patients and discovered these nano-sized particles can [...]
Groundbreaking AI Technology Diagnoses COVID-19 In Minutes
Pioneering Artificial Intelligence (AI) technology, developed by experts at University of the West of Scotland (UWS), is capable of accurately diagnosing Covid-19 in just a few minutes. The groundbreaking program is able to detect [...]
Antimicrobial resistance now a leading cause of death worldwide, study finds
Antimicrobial resistance poses a significant threat to humanity, health leaders have warned, as a study reveals it has become a leading cause of death worldwide and is killing about 3,500 people every day. More [...]
Leave A Comment